BofA Securities Reiterates Buy Rating on Ascendis Pharma (ASND), PT $175
Tweet Send to a Friend
BofA Securities analyst Tazeen Ahmad reiterated a Buy rating and $175.00 price target on Ascendis Pharma ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
